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including 42.9% genotype 1, 14.3% genotype 2, 19.0%
genotype 3 and 23.8% genotype 6. Genotype 1 was
predominant in Beijing, while genotype 6 was mainly
detected in Guangdong. The levels of IFN-g production
and antibody reactivity from chronic infection donors were
signiﬁcantly higher than those from recovery and false
positive infection donors (p < 0.001), but no statistical
difference of IFN-a among populations from three HCV
infection statuses was observed.
Conclusion: IFN-g but IFN-a may play a role paralleled with
antibody in viral clearance during natural history of HCV
infection.
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Background: Our previous study established that HCV
infection is wide-spread in Mongolia. So, many Government
and non-Government measures on HCV prevention are non-
speciﬁc. So, there is needed to check the results of the
measures.
Objective: To assess prevalence of HCV infection in
Mongolian children.
Methods: We randomly selected 199 “healthy” children
(ages 1 15) in May 2009, from Ulaanbaatar, matched by age
and sex and tested serum of all subjects for anti-HCV.
Results: Eighteen of 193 serum samples tested positive
for anti-HCV (9.3%). Older age was more likely to show a
positive test (presented in the table by age and sex).
Table 1. Anti HCV test results by age and number of subjects
Age Subjects Anti-HCV %
n male n male
1 21 12 0 0
3 24 14 0 0
5 28 14 3 2 10.7
7 26 12 0 0
9 26 13 4 3 15.4
11 23 12 3 2 13.0
13 23 10 3 1 13.0
15 22 12 5 2 22.7
Total 193 99 18 10 9.3
Discussion and Conclusion: More half the population of
Mongolia lives in Ulaanbaatar. We have carried two
studies on the prevalence of HCV infection in children in
Ulaanbaatar (1998, 2002). These studies did not showed
a signiﬁcant difference in HCV seroprevalcne between
rural and urban subjects. As the results, we estimate the
prevalence of HCV infection in Ulaanbaatar to the ﬁgure
for the whole Mongolian population. The seroprevalence,
found in this study is signiﬁcantly higher compared with our
previous study. Therefore, all measures to help prevent HCV
infection in Mongolia should be intensiﬁed.
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Background: HCV & HBV infections are known to be
major public health problem in Egypt. As chronic liver
disease progresses, an imbalance occurs between synthesis
and breakdown of extra cellular matrix (ECM). Matrix
metallproteinases (MMPs) are involved in degrading ECM
while tissue inhibitors of metalloproteinases (TIMPs) prevent
their ﬁbrolytic action. Transforming growth factor b1
(TGF-b1) is a key mediator of liver ﬁbrogenesis. Aim of this
study is evaluating TIMPs & TGF-b1 as ﬁbrogenic seromarkers
in comparison to histopathological examination of liver.
Methods: Commercially available ELISA assays were used
to study circulating levels of TIMP-1 & TGF-b1 in 50
patients with chronic hepatitis C patients and 20 patients
with chronic hepatitis B compared to 10 healthy control
subjects.
Results: In HCV patients, TIMP-1 was elevated with more
progresive liver disease with a sensitivity of 100% the
speciﬁcity of 87%. Serum level of TIMP-1 in chronic
hepatitis (B) was slightly decreased from healthy control
without signiﬁcant correlation. Its mean and standard
deviation was (157.81±44.1) and (164.18±42.22) in the
HBV and control group respectively.
In comparison between HCV & HBV patients there was
signiﬁcant increase in serum level of TIMP-1 in HCV patients
than HBV patients.
Serum levels of TGF-b1 were decreased in HCV patients
signiﬁcantly from healthy control group (mean 138.27±47.8)
to F4 patients (mean 46.97±23.49). Serum levels of
TGF-b1 in chronic hepatitis B patients showed no statistical
difference from the healthy control. Its mean and standard
deviation in HBV group and control group were (114.9±53.11
and 138.37±47.86) respectively.
Conclusion: TIMP-1 is a reliable predictor to detect
advanced ﬁbrosis, in HCV patients genotype 4.
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Hepatitis C virus (HCV)-speciﬁc T cell immunity was impaired
in HCV chronic infection and resulted in the persistence
of HCV infection. Dysfunction of dendritic cells (DCs) was
believed to be involved in this T cell exhaustion, but the
mechanisms were rarely understood.
In this study, we evaluated surface costimulatory marker
(CD83, CD86, and CD40) and coinhibitory marker (PD-L1)
expression and allostimulatory capacity of plasmacytoid
DCs and myeloid DCs in twenty ﬁve HCV-infected patients
compared to twenty healthy controls. All patients and
control were seronegative for anti-HIV and anti-HBV. DCs
were isolated from PBMC by use of BDCA-1 positive
cell isolation kit for myeloid DCs and BDCA-4 positive
cell isolation kit for plasmacytoid DCs according to the
manufacturer’s instructions.
We found both costimulatory marker and coinhibitory
marker expression were increased in HCV infection
compared with healthy control. The ratio of PD-L1 versus
CD86 was also increased in HCV-infected patients and
the ratio positive correlated with PD-L1 expression on
DCs. Allostimulatory capacity of DCs was impaired in HCV
infection and this allogeneic MLR was inversely correlated
with PD-L1 expression and PD-L1/CD86 ratio.
These ﬁndings suggested that the effect of inhibitory marker
PD-L1 overwhelmed the effect of costimulatory markers
and negatively regulated DC-T activation. Our ﬁnding will
be helpful to understand the mechanism of dysfunction
